Search Results 1391-1400 of 3939 for Oderant

  1. Vibegron (oral route) - Side effects & dosage - Mayo Clinic

    It is also used to treat symptoms of an overactive bladder in male patients taking medicine for benign prostatic hyperplasia (enlarged prostate). It helps ...

  2. Clinical trials - Oncology (Medical)

    Rochester, Minn. This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with ...

  3. Gastroesophageal reflux disease (GERD) - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  4. Study of DCC-3014 in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. Gastroesophageal reflux disease (GERD) - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  6. A Study To Evaluate The Effectiveness And Safety Of Vibegron Administered Orally For 12 Weeks To Women With Irritable Bowel Syndrome - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of vibegron, a beta-3 adrenergic receptor (β3-AR) agonist, in the treatment of pain ...

  7. Gastroesophageal reflux disease (GERD) - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  8. Pericarditis - Doctors and departments - Mayo Clinic

    Inflammation of the tissue surrounding the heart can cause sharp chest pain and other symptoms. Know how pericarditis is diagnosed and treated.

  9. A Phase 1b/2 Study of Onvansertib (PCM-075) in Combination with FOLFIRI and Bevacizumab for Second-Line Treatment of Metastatic Colorectal Cancer in Patients with a KRAS Mutation - Mayo Clinic

    Participants must have histologically confirmed metastatic and unresectable disease, and previously failed treatment or be intolerant to fluoropyrimidine and ...

  10. Gastroesophageal reflux disease (GERD) - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...